ATC code none PubChem CID 49779607 3D model (Jmol) Interactive image Pubchem 49779607 | CAS Number 1253641-65-4 Formula C30H25Cl2F3N4OS Molar mass 617.51 g/mol ChemSpider ID 29361353 | |
 | ||
TM-38837 is a small molecule inverse agonist/antagonist of the CB1 cannabinoid receptor, with peripheral selectivity. It is being developed for the treatment of obesity and metabolic disorders by 7TM Pharma. The company has announced phase I clinical trials.
TM-38837 is among the first of a new generation of cannabinoid receptor antagonist designed to avoid the central nervous system liabilities of the first generation CB1 receptor antagonists such as rimonabant.
References
TM-38837 Wikipedia(Text) CC BY-SA